Three more Legionnaires’ cases reported at Mount Carmel Grove City Hospital

One person who contracted Legionnaires’ has died


Three more cases of Legionnaires’ disease have been confirmed at Mount Carmel Grove City Hospital, in Grove City, Ohio, raising the total to 10 cases, according to an article on the Columbus Dispatch website.

One person who contracted Legionnaires’ has died, according to Franklin County Public Health.

Mount Carmel Health Systems initially announced Friday that there were seven victims of the disease at the new $361 million hospital that opened April 28. 

It is believed that patients were exposed sometime between April 27 and May 24.

Read the article.



June 10, 2019


Topic Area: Infection Control


Recent Posts

Healthcare and Resilience: A Pledge for Change

Climate resilience and reducing environmental impact drive voluntary program targeting hospitals.


Texas Health Resources Announces New Hospital for North McKinney

Expected to open in 2028, the hospital will feature 60 beds initially with plans to double in capacity to accommodate for future community growth.


Cedar Point Health Falls Victim to Data Breach

Cedar Point Health has no evidence directly linking this incident to specific incidents of financial fraud or identity theft.


Fire Protection in Healthcare: Why Active and Passive Systems Must Work as One

Sprinklers, smoke compartments and firestopping can form an interdependent safety strategy.


Cleveland Clinic Hits Key Milestones for Palm Beach County Expansion

These include plans to begin demolition of current structure and hospital site preparation in 2026 and open the outpatient center and ambulatory surgery center in 2027.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.